carbidopa, levodopa drug combination has been researched along with Anxiety in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, CH; Chen, NF; Chen, WF; Feng, CW; Hsiao, CD; Huang, SY; Hung, HC; Wang, HM; Wen, ZH; Yang, SN | 1 |
Arolt, V; Deckert, J; Dlugos, A; Domschke, K; Gajewska, A; Gieselmann, A; Herrmann, MJ; Jacob, C; Markulin, F; Mühlberger, A; Nienhaus, K; Notzon, S; Pauli, P; Reif, A; Unterecker, S; Warrings, B; Winter, B; Zwanzger, P | 1 |
Bellante, F; Dethy, S; Zegers de Beyl, D | 1 |
Chigir', IP; Fedorova, NV | 1 |
1 trial(s) available for carbidopa, levodopa drug combination and Anxiety
Article | Year |
---|---|
Multilevel impact of the dopamine system on the emotion-potentiated startle reflex.
Topics: Adult; Alleles; Anxiety; Arousal; Carbidopa; Catechol O-Methyltransferase; Dopamine; Double-Blind Method; Drug Combinations; Emotions; Female; Genotype; Humans; Levodopa; Male; Polymorphism, Genetic; Reflex, Startle | 2015 |
3 other study(ies) available for carbidopa, levodopa drug combination and Anxiety
Article | Year |
---|---|
Effects of 6-hydroxydopamine exposure on motor activity and biochemical expression in zebrafish (Danio rerio) larvae.
Topics: Animals; Antiparkinson Agents; Anxiety; Biomarkers; Blotting, Western; Carbidopa; Disease Models, Animal; Drug Combinations; Levodopa; Minocycline; Motor Activity; Oxidopamine; Parkinsonian Disorders; Real-Time Polymerase Chain Reaction; Sympatholytics; Vitamin E; Zebrafish; Zebrafish Proteins | 2014 |
Depression, anxiety and non-motor symptoms on initiation of intrajejunal levodopa/carbidopa therapy.
Topics: Adult; Aged; Antiparkinson Agents; Anxiety; Carbidopa; Depression; Drug Combinations; Female; Humans; Jejunum; Levodopa; Male; Middle Aged; Parkinson Disease; Prospective Studies; Psychiatric Status Rating Scales; Time Factors | 2016 |
[Dopamine receptors agonists (mirapex) in the treatment of Parkinson's disease].
Topics: Anxiety; Benzothiazoles; Carbidopa; Delayed-Action Preparations; Depression; Dopamine Agonists; Drug Combinations; Drug Therapy, Combination; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pramipexole; Receptors, Dopamine D1; Thiazoles; Treatment Outcome | 2006 |